Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000128279 | SCV000171871 | benign | not specified | 2014-02-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000541122 | SCV000633803 | likely benign | Early infantile epileptic encephalopathy with suppression bursts | 2024-01-16 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001311027 | SCV001501049 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | SPTAN1: BP4, BP7 |
Genome- |
RCV001808393 | SCV002056724 | benign | Developmental and epileptic encephalopathy, 5 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002381444 | SCV002670410 | likely benign | Inborn genetic diseases | 2018-04-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |